Navigation Links
Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug
Date:10/15/2008

BOULDER, Colo., Oct. 15 /PRNewswire/ -- Bolder BioTechnology, Inc. announced today that it has been awarded a $1.6 million Phase II Continuing Renewal Small Business Innovation Research (SBIR) grant, entitled "Long-Acting Beta Interferon for Multiple Sclerosis", from the National Institute of Neurological Disorders and Stroke (NINDS) of The National Institutes of Health (NIH). Receipt of the entire grant award is contingent upon the achievement of certain research milestones.

George (Joe) Cox, Ph.D., Company President and Principal Investigator for the grant, stated, "We are grateful to receive continued support from NINDS for our long-acting beta interferon program. With previous funding from NINDS we developed a novel beta interferon analog that has a longer duration of action and more potent biological activity than existing beta interferon products in animals. The new grant award will be used to perform preclinical studies required by the Food and Drug Administration for filing an Investigational New Drug application to begin testing our long-acting beta interferon analog in people. Recombinant beta interferon products have annual worldwide sales of approximately $5 billion, primarily from use of the drugs to treat Multiple Sclerosis. Multiple Sclerosis is a debilitating neurological disease that affects approximately 400,000 people in the United States and 2.5 million people worldwide. Current commercial beta interferon products are only partially effective and are inconvenient to use because they must be injected frequently, typically for the life of the patient. Our long-acting beta interferon analog was designed to provide patients with a more efficacious and easier to use product."

The NIH SBIR program is a peer-reviewed grant program that provides research support to small businesses to discover and develop innovative biomedical products for the treatment of serious unmet medical needs.

Bolder BioTechnology, Inc. uses advanced p
'/>"/>

SOURCE Bolder BioTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance
3. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
4. Lixte Biotechnology Holdings, Inc. Announces the Initial Trading of Its Common Stock Under the Symbol: LIXT
5. Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
6. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
7. Onyx Pharmaceuticals to Present at Biotechnology Industry Organization Investor Forum
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
10. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
11. Bionovo to Present at the Biotechnology Industry Organization (BIO) Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... NEW YORK , March 31, ... ), a biopharmaceutical company advancing protein biologic therapies ... its Korean marketing partner, Hanmi Pharmaceutical Co., Ltd ... Korea from the country,s Ministry of Food and ... Research Institute (KTR) for MuGard, its oncology supportive-care ...
(Date:3/31/2015)... Lighthouse Information Systems, Inc., a West ... Oregon, Washington and clients across the US, announces ... (M&A) Integration Services offering, effective immediately. ... M&A Integration Practice Leader at Lighthouse, explains, “Research ... M&A initiatives fail to achieve their intended economic ...
(Date:3/30/2015)... , March 30, 2015  NuGene International, ... subsidiary corporation, NuGene BioPharma, Inc. has added another ... Dr. Guan is an internationally recognized researcher ... his college education at Peking University, ... degree from the University of North Carolina, Chapel ...
(Date:3/30/2015)... Md. , March 30, 2015    ... leader in synthetic biology, and Merck Serono, the ... Germany , today announced an exclusive strategic ... Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. This ... develop innovative therapies that modulate the immune system,s ...
Breaking Biology Technology:PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4
... A. How is fold amplification , ... using the Van Gelder and Eberwine ... an oligo(dT) primer containing the T7 RNA polymerase , ... at the end of mRNA sequences serves as the substrate for the , ...
... , Quantitate gene ... 5 minute cell lysis , ... monitoring , siRNA-induced knockdown , ... Gene Expression Assays and SYBR Green , ...
... , , ... and validation Screening for miRNAs that regulate target , ... cellular process , ... RNAs that are expressed in animals and plants and affect the , ...
Cached Biology Technology:RNA Amplification for Array Analysis 2RNA Amplification for Array Analysis 3RNA Amplification for Array Analysis 4Ready for Real-time in 5 Minutes 2Ready for Real-time in 5 Minutes 3Ready for Real-time in 5 Minutes 4Ready for Real-time in 5 Minutes 5Ready for Real-time in 5 Minutes 6Precursor miRNAs for Successful miRNA Functional Studies 2Precursor miRNAs for Successful miRNA Functional Studies 3Precursor miRNAs for Successful miRNA Functional Studies 4Precursor miRNAs for Successful miRNA Functional Studies 5Precursor miRNAs for Successful miRNA Functional Studies 6Precursor miRNAs for Successful miRNA Functional Studies 7Precursor miRNAs for Successful miRNA Functional Studies 8Precursor miRNAs for Successful miRNA Functional Studies 9Precursor miRNAs for Successful miRNA Functional Studies 10Precursor miRNAs for Successful miRNA Functional Studies 11
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... the "Global Iris Recognition Market 2015-2019" report ... Global Iris Recognition market to grow at a CAGR ... This report covers the present scenario and the growth ... period 2015-2019. To calculate the market size, the report ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Levanger, Norway and Boulder, CO, USA -- April 10, ... a new collaboration to advance the clinical use of ... of biomarkers for the prediction of cardiovascular events such ... collaboration will analyze biological samples and clinical data from ...
... N.M. An air sampler the size of an ear ... to improve computer climate models. "We now have an ... said Sandia National Laboratories researcher Ron Manginell, lead author of ... , the often-cited journal of the American Institute of Physics. ...
... Alzheimer,s disease (AD) is now the sixth leading cause of death ... of 65. There is currently no treatment that alters the course ... changes in the way the body handles iron and other metals ... AD symptoms. A new study shows that reducing iron levels in ...
Cached Biology News:Miniature Sandia sensors may advance climate studies 2Miniature Sandia sensors may advance climate studies 3Miniature Sandia sensors may advance climate studies 4Miniature Sandia sensors may advance climate studies 5Antioxidant may disrupt Alzheimer's disease process 2
Request Info...
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
... [pTyr 209/ pSer 211 ] affinity isolated ... Dulbecco's phosphate buffered saline (without Mg 2+ ... mg/ml BSA (IgG and protease free) and 0.05% ... the region of mouse Hck that contains tyrosine ...
High voltage electrophoresis power supply...
Biology Products: